References
- Eichbaum MHR, Kaltwasser M, Bruckner T, De Rossi TM, Schneeweiss A, Sohn C. Prognostic factors for patients with liver metastases from breast cancer. Breast Cancer Res Treat 2006; 96: 53-62. doi: 10.1007/s10549-005-9039-1
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68: 7-30. doi: 10.3322/caac.21442
- Ruiz A, Sebagh M, Wicherts DA, Castro-Benitez C, Van Hillegersberg R, Paule B, et al. Long-term survival and cure model following liver resection for breast cancer metastases. Breast Cancer Res and Treat 2018; 170: 89-100. doi: 10.1007/s10549-018-4714-1
- Golse N, Adam R. Liver metastases from breast cancer: what role for surgery? Indications and results. Clin Breast Cancer 2017; 17: 256-65. doi: 10.1016/j.clbc.2016.12.012
- Ghersi D, Wilcken N, Simes RJ. A systematic review of taxane-containing regimens for metastatic breast cancer. Br J Cancer 2005; 93: 293-301. doi: 10.1038/sj.bjc.6602680
- Gordon AC, Uddin OM, Riaz A, Salem R, Lewandowski RJ. Making the case: intra-arterial therapy for less common metastases. Semin Intervent Radiol 2017; 34: 132-9. doi: 10.1055/s-0037-1601852
- Smits ML, Prince JF, Rosenbaum CE, van den Hoven AF, Nijsen JF, Zonnenberg BA, et al: Intra-arterial radioembolization of breast cancer liver metastases: a structured review. Eur J Pharmacol 2013; 709: 37-42. doi: 10.1016/j.ejphar.2012.11.067
- Wang M, Zhang J, Ji S, Shao G, Zhao K, Wang Z, et al. Transarterial chemoembolisation for breast cancer with liver metastasis: a systematic review. Breast 2017; 36: 25-30. doi: 10.1016/j.breast.2017.09.001
- Aarts BM, Klompenhouwer EG, Dresen RC, Laenen A, Beets-Tan RGH, Punie K, et al. Intra-arterial mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival. Breast Cancer Res Treat 2019; 176: 597-605. doi: 10.1007/s10549-019-05254-4
- Fendler WP, Lechner H, Todica A, Paprottka KJ, Paprottka PM, Jakobs TF, et al. Safety, efficacy and prognostic factors after radioembolization of hepatic metastases from breast cancer: a large single center experience in 81 patients. J Nucl Med 2016; 57: 517-23. doi: 10.2967/jnumed.115.165050
- Pieper CC, Meyer C, Wilhelm KE, Block W, Nadal J, Ahmadzadehfar H, et al. Yttrium-90 radioembolization of advanced, unresectable breast cancer liver metastases-a single-center experience. J Vasc Interv Radiol 2016; 27: 1305-15. doi: 10.1016/j.jvir.2016.05.028
- Gordon AC, Salem R, Lewandowski RJ. Yttrium-90 radioembolization for breast cancer liver metastases. J Vasc Interv Radiol 2016, 27: 1316-9. doi: 10.1016/j.jvir.2016.06.016
- Maleux G, Deroose C, Laenen A, Verslype C, Heye S, Haustermans K et al. Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: technical results, clinical outcome and factors potentially influencing survival. Acta Oncologica 2016; 55: 486-95. doi: 10.3109/0284186X.2015.1101151
- Maes T, Wildiers H, Heye S, Demey W, Maleux G, Neven P, et al. Intrahepatic mitomycin C bolus infusion in the treatment of extensive liver metastases of breast cancer. Breast Cancer Res Treat 2008; 110: 135-42. doi:10.1007/s10549-007-9707-4
- Tirkes T, Hollar MA, Tann M, Kohli MD, Akisik F, Sandrasegaran K. Response criteria in oncologic imaging: review of traditional and new criteria. Radiographics 2013; 33: 1323-41. doi: 10.1148/rg.335125214
- Pieper CC, Willinek WA, Thomas D, Ahmadzadehfar H, Essler M, Nadal J, et al: Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis. Eur Radiology 2016; 26: 2779-89. doi: 10.1007/s00330-015-4076-6
- Collins J, Salem R. Hepatic radioembolization complicated by gastrointestinal ulceration. Semin Intervent Radiol 2011; 28: 240-5. doi: 10.1055/s-0031-1280673
- Saxena A, Kapoor J, Meteling B, Morris DL, Bester L. Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients. Ann Surg Oncol 2014; 21: 1296-303. doi: 10.1245/s10434-013-3436-1
- Bangash AK, Atassi B, Kaklamani V, Rhee TK, Yu M, Lewandowski RJ, et al. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival. J Vasc Interv Radiol 2007; 18: 621-8. doi: 10.1016/j. jvir.2007.02.019
- Jakobs TF, Hoffmann RT, Fischer T, Stemmler HJ, Tatsch K, La Fougere C, et al. Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 2008; 19: 683-90. doi: 10.1016/j.jvir.2008.01.009